Last reviewed · How we verify

NCT06681935

Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery

Recruiting now Last updated 21 May 2025
What this trial tests

trial testing Oral Cavity Reconstruction in Oral Cancer in 40 participants. Currently enrolling.

Timeline
29 April 2025
Primary endpoint
1 May 2027
1 May 2027

Quick facts

Lead sponsorMedical College of Wisconsin
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment40
Start date29 April 2025
Primary completion1 May 2027
Estimated completion1 May 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medical College of Wisconsin

Who can join

21 and older, any sex, with Oral Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study design is an observational cohort study of patients undergoing standard of care oral cavity reconstruction. An observational study is required to prospectively evaluate microbial and antibiotic mechanisms underlying surgical site infection after oral cavity reconstruction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Oral Cancer

Currently open trials in the same condition.

Other Medical College of Wisconsin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06681935.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing